Development of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale, associated with nanoparticles adjuvants.

GASPAR, E. B.; SANTOS, L. R.; ARAÚJO, F. R.; GULIAS-GOMES, C. C.; LINCOPAN, N.; BRANDÃO, H. M.; ROSINHA, G. M. S.; EMANUELLE BALDO GASPAR, CPPSUL; CNPGC; CNPGC; CLAUDIA CRISTINA GULIAS GOMES, CPPSUL; USP; CNPGL; CNPGC.

Development of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale, associated with nanoparticles adjuvants.

Saved in:

Bibliographic Details
Main Authors:	GASPAR, E. B., SANTOS, L. R., ARAÚJO, F. R., GULIAS-GOMES, C. C., LINCOPAN, N., BRANDÃO, H. M., ROSINHA, G. M. S.
Other Authors:	EMANUELLE BALDO GASPAR, CPPSUL; CNPGC; CNPGC; CLAUDIA CRISTINA GULIAS GOMES, CPPSUL; USP; CNPGL; CNPGC.
Format:	Parte de livro biblioteca
Language:	pt_BR por
Published:	2012-12-06
Subjects:	Vacina.,
Online Access:	http://www.alice.cnptia.embrapa.br/alice/handle/doc/941621
Tags:	Add Tag No Tags, Be the first to tag this record!

id	dig-alice-doc-941621
record_format	koha
spelling	dig-alice-doc-9416212017-08-15T23:12:57Z Development of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale, associated with nanoparticles adjuvants. GASPAR, E. B. SANTOS, L. R. ARAÚJO, F. R. GULIAS-GOMES, C. C. LINCOPAN, N. BRANDÃO, H. M. ROSINHA, G. M. S. EMANUELLE BALDO GASPAR, CPPSUL; CNPGC; CNPGC; CLAUDIA CRISTINA GULIAS GOMES, CPPSUL; USP; CNPGL; CNPGC. Vacina. 2012-12-12T12:43:01Z 2012-12-12T12:43:01Z 2012-12-06 2012 2012-12-12T12:43:01Z Parte de livro In: SIMPÓSIO EMBRAPA LABEX EUA DE SANIDADE ANIMAL, 2., 2012, Brasília, DF. Anais... Brasília, DF: Embrapa Estudos e Capacitação, 2012. http://www.alice.cnptia.embrapa.br/alice/handle/doc/941621 pt_BR por openAccess p. 153.
institution	EMBRAPA
collection	DSpace
country	Brasil
countrycode	BR
component	Bibliográfico
access	En linea
databasecode	dig-alice
tag	biblioteca
region	America del Sur
libraryname	Sistema de bibliotecas de EMBRAPA
language	pt_BR por
topic	Vacina. Vacina.
spellingShingle	Vacina. Vacina. GASPAR, E. B. SANTOS, L. R. ARAÚJO, F. R. GULIAS-GOMES, C. C. LINCOPAN, N. BRANDÃO, H. M. ROSINHA, G. M. S. Development of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale, associated with nanoparticles adjuvants.
author2	EMANUELLE BALDO GASPAR, CPPSUL; CNPGC; CNPGC; CLAUDIA CRISTINA GULIAS GOMES, CPPSUL; USP; CNPGL; CNPGC.
author_facet	EMANUELLE BALDO GASPAR, CPPSUL; CNPGC; CNPGC; CLAUDIA CRISTINA GULIAS GOMES, CPPSUL; USP; CNPGL; CNPGC. GASPAR, E. B. SANTOS, L. R. ARAÚJO, F. R. GULIAS-GOMES, C. C. LINCOPAN, N. BRANDÃO, H. M. ROSINHA, G. M. S.
format	Parte de livro
topic_facet	Vacina.
author	GASPAR, E. B. SANTOS, L. R. ARAÚJO, F. R. GULIAS-GOMES, C. C. LINCOPAN, N. BRANDÃO, H. M. ROSINHA, G. M. S.
author_sort	GASPAR, E. B.
title	Development of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale, associated with nanoparticles adjuvants.
title_short	Development of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale, associated with nanoparticles adjuvants.
title_full	Development of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale, associated with nanoparticles adjuvants.
title_fullStr	Development of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale, associated with nanoparticles adjuvants.
title_full_unstemmed	Development of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale, associated with nanoparticles adjuvants.
title_sort	development of recombinant vaccine against tick fever disease based on chimeric protein of babesia sp and anaplasma marginale, associated with nanoparticles adjuvants.
publishDate	2012-12-06
url	http://www.alice.cnptia.embrapa.br/alice/handle/doc/941621
work_keys_str_mv	AT gaspareb developmentofrecombinantvaccineagainsttickfeverdiseasebasedonchimericproteinofbabesiaspandanaplasmamarginaleassociatedwithnanoparticlesadjuvants AT santoslr developmentofrecombinantvaccineagainsttickfeverdiseasebasedonchimericproteinofbabesiaspandanaplasmamarginaleassociatedwithnanoparticlesadjuvants AT araujofr developmentofrecombinantvaccineagainsttickfeverdiseasebasedonchimericproteinofbabesiaspandanaplasmamarginaleassociatedwithnanoparticlesadjuvants AT guliasgomescc developmentofrecombinantvaccineagainsttickfeverdiseasebasedonchimericproteinofbabesiaspandanaplasmamarginaleassociatedwithnanoparticlesadjuvants AT lincopann developmentofrecombinantvaccineagainsttickfeverdiseasebasedonchimericproteinofbabesiaspandanaplasmamarginaleassociatedwithnanoparticlesadjuvants AT brandaohm developmentofrecombinantvaccineagainsttickfeverdiseasebasedonchimericproteinofbabesiaspandanaplasmamarginaleassociatedwithnanoparticlesadjuvants AT rosinhagms developmentofrecombinantvaccineagainsttickfeverdiseasebasedonchimericproteinofbabesiaspandanaplasmamarginaleassociatedwithnanoparticlesadjuvants
_version_	1756017733230657536

Development of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale, associated with nanoparticles adjuvants.

Similar Items

Resource Map